ZIM LABORATORIES LIMITED

ZIM LABORATORIES LIMITED We offer both pharmaceutical and nutraceutical products.

We are research driven pharmaceutical company who develop, manufacture and supply differentiated generic products in the oral solid dosage forms, both as pre-formulation intermediates as well as finished formulation for certain key therapeutic segments. We have in-house R&D capabilities to offer a range of non-infringing drug delivery solutions based on process technologies that bring patient compliance thereby reducing the cost of treatment.

Manufacturers of supplements today operate in an environment defined by​Regulatory divergence​Ingredient variability​Sta...
11/05/2026

Manufacturers of supplements today operate in an environment defined by​

Regulatory divergence​

Ingredient variability​

Stability risks​

Rising consumer expectations around safety and transparency​

Sustainable growth is shaped by scientific rigour, regulatory readiness, and operational resilience.​

In our latest blog, we break down the top five challenges dietary supplement makers face, and how a capable CDMO addresses them.​

Read the full blog to explore how we support manufacturers of supplements in building future-ready portfolios- https://www.zimlab.in/blog-posts/cdmo-vs-cmo-vs-cro-contract-manufacturing-in-pharma-explained

[ZIMLabs, Finished dosage formulations, Pharmaceutical Formulation Development, Pharmaceutical Products Manufacturing company, Pharmaceutical manufacturer in india, Generic drug manufacturers in india, pharmaceutical manufacturer, pharmaceutical product development, sublingual, pharmaceutical formulation, novel dosage form, Oral Thin Films Products]

Some forms of care shape a lifetime. Today is about appreciating hers.​Happy Mother's Day​​
10/05/2026

Some forms of care shape a lifetime. Today is about appreciating hers.​

Happy Mother's Day​

​

Whether a product falls under FSSAI or CDSCO determines its approval pathway, claim scope, manufacturing standards, and ...
08/05/2026

Whether a product falls under FSSAI or CDSCO determines its approval pathway, claim scope, manufacturing standards, and labeling requirements.​

Understanding this regulatory divide is essential to portfolio planning, risk mitigation, and market positioning for manufacturers of supplements.​

To navigate India’s nutraceutical regulatory ecosystem with confidence, get in touch with us through the link in bio.​

Swipe through and save this post.​

[ZIMLabs, Finished dosage formulations, Pharmaceutical Formulation Development, Pharmaceutical Products Manufacturing company, Pharmaceutical manufacturer in india, Generic drug manufacturers in india, pharmaceutical manufacturer, pharmaceutical product development, sublingual, pharmaceutical formulation, novel dosage form, Oral Thin Films Products]

06/05/2026

Certain APIs are highly sensitive to elevated temperatures encountered during conventional manufacturing processes. Without the right formulation and processing strategy, exposure to heat can affect API stability and reduce therapeutic effectiveness.​

ZIM Labs works closely with partners to address these challenges with Pellet Cold Forming Technology (PCFT).​

To develop formulations designed to preserve stability even under demanding manufacturing conditions, partner with ZIM Labs. Click on the link in bio.​

[ZIMLabs, Finished dosage formulations, Pharmaceutical Formulation Development, Pharmaceutical Products Manufacturing company, Pharmaceutical manufacturer in india, Generic drug manufacturers in india, pharmaceutical manufacturer, pharmaceutical product development, sublingual, pharmaceutical formulation, novel dosage form, Oral Thin Films Products]

The global urology supplements market is projected to reach USD 2.7 billion by 2029, expanding at a CAGR of 8.4%.​Consum...
04/05/2026

The global urology supplements market is projected to reach USD 2.7 billion by 2029, expanding at a CAGR of 8.4%.​

Consumers are increasingly using nutritional supplements as a part of long-term urological wellness strategies.​

To understand how manufacturers of supplements support urology portfolios, read our latest blog through the link in bio.​

[ZIMLabs, Finished dosage formulations, Pharmaceutical Formulation Development, Pharmaceutical Products Manufacturing company, Pharmaceutical manufacturer in india, Generic drug manufacturers in india, pharmaceutical manufacturer, pharmaceutical product development, sublingual, pharmaceutical formulation, novel dosage form, Oral Thin Films Products]

It’s the dedication, resilience, and quiet effort that shape everything we do. Thank you to our team for being the stren...
01/05/2026

It’s the dedication, resilience, and quiet effort that shape everything we do. Thank you to our team for being the strength that keeps us moving forward.​

30/04/2026

The global hair supplements market is estimated to reach USD 2.69 billion in the next four years.​

For manufacturers of supplements, hair nutrition represents a formulation-led, brand-driven opportunity within the broader nutraceutical innovation.​

To explore hair supplement manufacturing support, reach out to us through the link in bio.​

[ZIMLabs, Finished dosage formulations, Pharmaceutical Formulation Development, Pharmaceutical Products Manufacturing company, Pharmaceutical manufacturer in india, Generic drug manufacturers in india, pharmaceutical manufacturer, pharmaceutical product development, sublingual, pharmaceutical formulation, novel dosage form, Oral Thin Films Products]

According to the India Ageing Report 2023, India had​149 million individuals aged 60 and above in 2022 (10.5 percent of ...
28/04/2026

According to the India Ageing Report 2023, India had​

149 million individuals aged 60 and above in 2022 (10.5 percent of the population.)​

That number is projected to reach 347 million by 2050 (20.8 percent of the population.)​

Combined with Vitamin D deficiency rates between 50-90%, this isn't a trend, it's a structural market shift. ​

Brands entering or expanding in the Vitamin D space need manufacturing partners who understand manufacturing science, regulatory compliance, and scale. That's what ZIM Labs is built for. Connect with us through the link in bio.​

[ZIMLabs, Finished dosage formulations, Pharmaceutical Formulation Development, Pharmaceutical Products Manufacturing company, Pharmaceutical manufacturer in india, Generic drug manufacturers in india, pharmaceutical manufacturer, pharmaceutical product development, sublingual, pharmaceutical formulation, novel dosage form, Oral Thin Films Products]

24/04/2026

We are pleased to announce the opening of our new office in Mumbai, India, marking an important step forward in our journey of growth and expansion.​

This new space reflects the continued evolution of our work, the strengthening of our capabilities, and our commitment to building a future shaped by collaboration, quality, and purpose.​

As we establish our presence in one of India’s most dynamic business hubs, we remain grounded in what has always defined us - our people, our values, and our shared commitment to excellence.​

A huge congratulations to everyone at ZIM Labs. This celebration of new beginnings truly belongs to all of us. We thank the team for the dedication, hard work, and the energy brought in every day. It is the collective effort that continues to shape milestones like this.

Here’s to new spaces, shared ambition, and the journey ahead.​

[ZIMLabs, Finished dosage formulations, Pharmaceutical Formulation Development, Pharmaceutical Products Manufacturing company, Pharmaceutical manufacturer in india, Generic drug manufacturers in india, pharmaceutical manufacturer, pharmaceutical product development, sublingual, pharmaceutical formulation, novel dosage form, Oral Thin Films Products]

23/04/2026

The global dietary supplements contract manufacturing market is projected to grow at a CAGR of 12.6% from 2025 to 2030.​

But fast markets punish slow manufacturers. Brands that win are partnering with manufacturers who can​

Scale portfolios​

Manage regulatory complexity​

Maintain quality consistency across markets​

​To explore reliable, technology-driven partnerships, get in touch with us.​

[ZIMLabs, Finished dosage formulations, Pharmaceutical Formulation Development, Pharmaceutical Products Manufacturing company, Pharmaceutical manufacturer in india, Generic drug manufacturers in india, pharmaceutical manufacturer, pharmaceutical product development, sublingual, pharmaceutical formulation, novel dosage form, Oral Thin Films Products]

Oral thin films are increasingly getting recognized as a medicine-on-the-go format, supporting portability, faster onset...
20/04/2026

Oral thin films are increasingly getting recognized as a medicine-on-the-go format, supporting portability, faster onset, and simpler dosing.​

To explore oral thin film format for your APIs, schedule a consultation with us.​

[ZIMLabs, Finished dosage formulations, Pharmaceutical Formulation Development, Pharmaceutical Products Manufacturing company, Pharmaceutical manufacturer in india, Generic drug manufacturers in india, pharmaceutical manufacturer, pharmaceutical product development, sublingual, pharmaceutical formulation, novel dosage form, Oral Thin Films Products]

Address

B-21/22, MIDC Area, Kalameshwar
Nagpur
441501

Opening Hours

Monday 9am - 5:30pm
Tuesday 9am - 5:30pm
Wednesday 9am - 5:30pm
Thursday 9am - 5:30pm
Friday 9am - 5:30pm
Saturday 9am - 5:30pm
Sunday 9am - 5:30pm

Telephone

07118271370

Website

Alerts

Be the first to know and let us send you an email when ZIM LABORATORIES LIMITED posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category